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The rapid rise of allergic disorders in developed countries has been attributed to 
the hygiene hypothesis, implicating that increased environmental sanitation in early 
childhood may be associated with higher incidence of hypersensitivity. Intestinal 
epithelial barriers play a crucial role in the maintenance of gut homeostasis by limit-
ing penetration of luminal bacteria and dietary allergens, yet allowing antigen sam-
pling via the follicle-associated epithelium for generation of tolerance. However, 
this intricate balance is upset in allergic intestines, whereby luminal proteins with 
antigenic properties gain access to the subepithelial compartment and stimulate 
mast cell degranulation. Recent studies demonstrated that food allergens were 
protected from lysosomal degradation, and were transported in large quantities 
across the epithelium by binding to cell surface IgE/CD23 (FcεRII) that prevented 
the antigenic protein from lysosomal degradation in enterocytes. IL-4 (a Th2-type 
cytokine) not only increased production of IgE from B cells, but also upregulated 
the expression of CD23 on intestinal epithelial cells. Further studies indicated that 
CD23 was responsible for the bidirectional transport of IgE across epithelium. The 
presence of IgE/CD23 opens a gate for intact dietary allergens to transcytose across 
the epithelial cells, and thus foments the mast cell-dependent anaphylactic 
responses. The understanding of the molecular mechanism responsible for epithe-
lial barrier defects may be helpful in designing novel therapies to treat food allergy 
and other allergic diseases.
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1. Clinical Prevalence of Food Allergies
Increasing prevalence of allergic diseases, such as 
asthma, hay fever, eczema and food allergies, has 
been observed in recent decades. The number of 
visits due to food-induced anaphylaxis is growing 
in hospital emergency departments and has signifi-
cantly increased the burden on medical systems.1,2 
Food allergy is reported in 6−10% of the pediatric 
population, and is more frequent in children than 
adults.3,4 The most common allergens include cow’s 
milk, eggs, peanuts, and seafood. Cow’s milk allergy 
occurs in 2−3% of the infant population, and is mostly 
diagnosed within the first month of life. Egg allergy 
is seen in 1−2% and peanut allergy in 0.3% of children. 
Although some types of food allergy, e.g. cow’s milk, 
remit spontaneously during the first few years of life, 
they are often associated with later development 
of respiratory and skin allergic manifestations.3,4
2. Hygiene Hypothesis
The rapid rise of allergic disorders in developed 
countries has led to the postulation that lower in-
cidence of microbial infection in early childhood—
due to increased environmental sanitation—may be 
associated with higher incidence of hypersensitivity.5 
This is termed the hygiene hypothesis. This hypo-
thesis was originally formed in 1989 by Strachan, 
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an epidemiologist, who observed an inverse correla-
tion between family size and the occurrence of at-
opic diseases.6 Speculations were formed that smaller 
household size indicated less cross-infection between 
family members/siblings—this could be related to 
the development of allergic disorders in individuals. 
This phenomenon was coined the “post-industrial 
revolution epidemic”. In the following years, aller-
gists and immunologists further broadened the 
concept that reduced exposure to microorganisms 
and microbial products, and increased inoculation 
of antibiotics and vaccines at a young age may pre-
dispose individuals to allergic diseases.6,7
3. Oral Tolerance and Allergy
Oral tolerance has been defined as a systemic im-
mune unresponsiveness to a specific antigen which 
was previously orally administered. Studies in ex-
perimental models show that the dose and frequency 
of antigen feeding influences the course of tolerance 
acquisition.8,9 The putative concept is that feeding 
a high dosage of antigen results in clonal deletion 
or anergy of specific T cell clones that involve Fas/
FasL-dependent apoptosis, whereas feeding a low 
dosage of antigen favors the pathway of active sup-
pression following the induction of regulatory T (Treg) 
cells in the Peyer’s patches (PP). However, it should 
be kept in mind that the two forms of tolerance 
are not mutually exclusive but are likely to be 
overlapped in physiological situations.
PPs are specialized lymphoid follicles in the gut 
that are implicated as a crucial site for induction 
of oral tolerance. Luminal antigens are readily taken 
up by follicle-associated epithelium (mainly by 
M cells) on PP and delivered to the underlying den-
dritic cells and lymphocytes for trafficking to me-
senteric lymph nodes (MLN).10,11 Previous studies 
demonstrated that lymphotoxin (LT)α knock-out 
mice, or mice treated in utero with LTβ receptor-
blockade, are devoid of PP and MLN, and fail to de-
velop oral tolerance.12,13 However, mesenteric lymph 
nodes have been suggested to be responsible for 
the induction of high-dose oral tolerance in the 
absence of PP. An elegant study showed that by treat-
ing pregnant LTα knock-out mice with an agonist 
anti-LTβR monoclonal antibody, their progeny devel-
oped MLN but without PP and readily acquired 
systemic tolerance to the orally administered 
protein.14,15
Following antigen feeding, the presence of 
antigen-specific CD4 + CD25 + Treg cells and secretion 
of suppressive cytokines, e.g. transforming growth 
factor (TGF) β, are found in the PP compartment.16−19 
The involvement of TGFβ in oral tolerance induc-
tion was first suggested in studies using oral feeding 
of myelin basic protein to suppress experimental 
autoimmune encephalomyelitis.20 Neutralizing an-
tibody to TGFβ inhibited the bystander suppression 
of immune responses conferred by tolerized T cells 
in vitro.20 Further evidence indicated that TGFβ 
played a complementary role in facilitating the in-
duction of low dose antigen-induced oral tolerance 
by CD4 + CD25 + Treg cells and was crucial for the 
maintenance of established tolerance.21,22 Moreover, 
oral administration of TGFβ along with antigen 
augments the reduction of antigen-specific immu-
noglobulin levels, T-cell reactivity, and immediate 
skin hypersensitivity compared with antigen feed-
ing alone.22
Treg cells mediate active suppression and are 
primary effector cells involved in the generation of 
oral tolerance. Oral administration of ovalbumin 
to ovalbumin TCR transgenic mice resulted in a rel-
ative increase in the population of CD4 + CD25 + Tregs 
expressing CTLA-1. Adoptive transfer of these 
CD4 + CD25 + Tregs from antigen-fed ovalbumin TCR 
transgenic mice suppressed the delayed type hy-
persensitivity responses in recipient mice, suggest-
ing that this particular cell type is responsible for 
oral tolerance induction to specific antigens.23 
Recent data indicated that a dendritic cell subset 
in the lamina propria characterized by the expres-
sion of CD103 induced naive T cells to differenti-
ate into CD4 + CD25 + Foxp3 + Treg cells, via a TGFβ 
and retinoic acid-dependent mechanism.24,25
Dysregulation of various functions in PP may pro-
mote allergic sensitization. Studies using milk al-
lergic mice have shown that enhanced transfer of 
aggregates through PP or abnormal interaction be-
tween lymphocytes and dendritic cells in PP favors 
the development of food allergy.18,26,27 Orally ad-
ministered aggregated proteins were redirected to 
uptake through PP which promoted a significant 
Th2 response and triggered allergic sensitization in 
a cow’s milk-allergic mouse model.27 Interestingly, 
subsequent anaphylaxis was only elicited by orally 
given soluble, but not aggregated, forms of allergen. 
The findings suggested that the transport of solu-
ble protein via villous epithelial cells was the main 
pathway for anaphylactic responses.27
In healthy individuals, the colonic lumen hosts 
over 100 trillion commensal bacteria forming the en-
teric microfloral population, and is established after 
birth.28 Enteric bacteria are involved in numerous 
protective and metabolic functions of the gut, such 
as preventing colonization of pathogens, degrading 
non-digestible dietary substances, producing short 
chain fatty acids and vitamins, and shaping the mu-
cosal immunity.28−31 The intestinal IgA production 
is profoundly affected by the colonization of com-
mensal microflora, as shown by the low levels of 
IgA in germ-free animals, which is corrected after 
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inoculation of luminal bacteria.32 Luminal antigen 
sampling by PP induces class switch recombination of 
IgM-positive B cells to IgA. The classing switching of 
IgA is partially dependent on presence of TGFβ and 
production of retinoic acid by intestinal dendritic 
cells.33,34 These IgA-committed B cells drain to the 
mesenteric lymph nodes, subsequently enter the 
thoracic duct and bloodstream, and finally home 
back to the intestinal mucosa. The secretory IgA 
(sIgA) produced by these lamina propria plasma cells 
is transported across the intestinal epithelium via 
the polymeric immunoglobulin receptor into the 
lumen.35 Enteric bacteria are coated with sIgA.36 
Recent studies showed that luminal sIgA selectively 
adhered to M cells in the mouse and human intestinal 
PP via a novel IgA receptor—this also mediated trans-
location of bacteria and antigenic products to the 
underlying dendritic cells.37,38 The bacteria trans-
ported by the sIgA across M cells further induces 
naïve B cells to differentiate into IgA-committed 
plasma cells.39 The roundtrip, bidirectional transport 
of sIgA and sIgA-mediated bacterial coatings have 
been implicated in the mechanism of antigen neu-
tralization that curtails bacterial overgrowth.40,41
Recent evidence indicated that gut bacterial 
flora is required for the induction of oral tolerance. 
In contrast to conventionally-raised animals, germ-
free mice do not generate immune tolerance against 
fed antigen.42,43 Mice given oral antibiotics during 
infancy showed an increase in serum levels of IgG1 
and IgE, and decreased IgG2a levels that are asso-
ciated with enhanced IL-4 secretion in stimulated 
spleen cells, suggesting a Th2-polarized immune 
response.44 The absence of T cells in PP under 
germ-free conditions was implicated in the mecha-
nism of failure of tolerance induction.45
4. Immunological Basis of Food Allergy
Food allergy is characterized by sensitization to 
specific dietary antigens and local inflammation at 
the encountering site of allergens. The onset of 
sensitization involves the combination of a number 
of factors including genetic traits, allergen expo-
sure, intestinal microflora, and environmental stim-
uli. Recent evidence has suggested that psychological 
stress also predisposes animals to sensitization 
against orally given antigens which otherwise induced 
tolerance.46
The sensitization phase of allergy is character-
ized by the production of IgE and Th2-type cy-
tokine (IL-4, IL-5, and IL-13) responses. Elevated 
production of IL-4 by mononuclear cells has been 
demonstrated in the blood and intestinal mucosa 
of atopic individuals.47,48 IL-4 induces germ line ε 
transcript for isotype class switching in B cells and 
promotes B cell proliferation to increase the syn-
thesis of antigen-specific IgE.49 In addition to its 
presence in serum, elevated levels of IgE are de-
tected in the intestinal fluid in food-allergic pa-
tients, suggesting that IgE is also secreted into the 
gut lumen.50,51 In parasite-infected rats with stim-
ulated IgE production, the concentration of IgE in 
the intestinal fluid was greater than that in the 
serum or mesenteric lymph.52 A previous study dem-
onstrated that radiolabeled IgE (but not IgG) was 
translocated from the serum into the gut wall and 
lumen after infusion of rats with IL-4.53
IgE binding to the high affinity FcεRI on the 
surface of mast cells represents the hallmark of 
allergy. Cross-linking of IgE by specific antigen in-
duces mast cell degranulation and release of me-
diators, thereby causing anaphylactic responses.54 
Anaphylactic reactions in food allergy are associ-
ated with enhanced epithelial ionic transport with 
passive out flux of water—this is responsible for 
clinical diarrheal symptoms.55,56 Mast cell media-
tors, e.g. histamine and prostaglandin, are involved 
in the stimulation of epithelial ion secretion.57,58 
Histamine evokes chloride secretion in epithelial 
cell monolayers through H1-receptors on intestinal 
epithelial cells, causing elevation in cytosolic cal-
cium level and protein kinase C activation.59,60 
Prostaglandins have been shown to increase the se-
cretory response of intestinal epithelial monolay-
ers directly via cAMP upregulation, or to serve as a 
mediation step for ion secretion induced by sev-
eral cytokines and mediators, such as TNFα, sero-
tonin, leukotrienes, and proteases.61−63
5.  Epithelial Barrier Defects in 
Intestinal Allergy
It is generally accepted that intestinal anaphylac-
tic reactions are caused by biological mediators 
released from mucosal mast cells after antigen 
cross-linking of IgE bound to the cell surface. 
However, macromolecular food antigens must first 
cross the intestinal epithelial barrier before gain-
ing access to mast cells in the subepithelial com-
partment. Abnormal antigen passage through PP has 
been suggested as one of the mechanisms respon-
sible for the lack of tolerance.18,26,27 In comparison 
to the limited exposing region of PPs, villous epi-
thelium constitutes a relatively large surface area 
and plays a more important role in responsible for 
the breach of barrier in intestinal allergy.
Physiologically, most dietary proteins are digested 
by luminal gastric and pancreatic proteases as well 
as integral brush border enzymes. They are con-
verted to small peptides and amino acids, which are 
then absorbed by enterocytes via electrogenic or 
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sodium-dependent transporters. Although a small 
amount of intact protein is endocytosed by intestinal 
epithelial cells in normal conditions, most of it is 
sorted into lysosomal compartments for degradation 
and therefore, transcytosis of whole proteins are 
prevented.64−66 In other words, the transcellular 
route across epithelial cells contributes partially to 
exclusion of luminal proteins with antigenic proper-
ties. The intestinal epithelial cells are joined at their 
apical side by tight junctions.67,68 The transmembra-
nous junctional proteins, e.g. claudins, occludin or 
junction-associated molecules, are linked to intrac-
ellular zonula occludens which are bridges to cy-
toskeletal actin and myosin filaments. The tight 
junctional complexes are the rate-limiting step for 
paracellular diffusion, and only permit small mole-
cules lesser than 500 daltons to cross between 
cells. Focal disorganization of tight junctional pro-
teins or circumferential contraction of the perijunc-
tional actomyosin ring may increase paracellular 
permeability.69−73
The place in which route food allergens cross the 
gut epithelium has been extensively explored in 
the last decade. In rodent models, it was observed 
that addition of antigen from the luminal or serosal 
side of the allergic intestine induces strong ion se-
cretory responses, with different timeframes. Antigen 
challenge to the serosal side of the intestine induces 
an immediate increase (approximately 30 seconds) 
in ion secretion, whereas luminal addition of antigen 
results in a lag phase (approximately 3 minutes) 
before the occurrence of the secretory response, 
mediated by mast cell activation.57 The lag phase 
of the anaphylactic response after luminal chal-
lenge appears to reflect the time for antigen trans-
port across the intestinal epithelial cells to activate 
mast cells in the lamina propria.57
In contrast to protein degradation in normal in-
testinal epithelial cells, enhanced rates of transcy-
tosis of intact proteins was documented in allergic 
animals.74,75 Previous studies modeling luminal al-
lergen challenge demonstrated that increased an-
tigen uptake was observed within the endosomal 
compartment of jejunal enterocytes in sensitized 
rats before mast cell activation.74,76,77 Studies using 
sensitized Ws/Ws rats (mast cell-deficiency due to 
mutation of the c-kit gene) and mast cell stabilizing 
agents provided evidence that mast cell activation 
does not play a role in the mechanism of height-
ened apical-to-basolateral transcellular transport 
of antigen at this timepoint.76 The uptake of antigen 
appeared to be specific and the transport pathway 
was exclusively transcellular within the first 2 min-
utes post-challenge. This period of specific trans-
cellular antigen transport before mast cell activation 
was termed phase I.76,77 The period following mast 
cell activation by epithelial ion secretory response 
was termed phase II (Figure 1). During phase II, anti-
gens were visualized not only inside endosomes 
but also within the tight junctions and paracellular 
Figure 1 Intestinal epithelial barrier defects in food allergy. Physiologically, most dietary proteins are digested to small 
peptides and amino acids before being absorbed into enterocytes. A very small percentage of intact proteins may be 
endocytosed into epithelial cells but are degraded by lysozymes and lose their antigenic properties. In food allergy, 
IL-4 (a Th2-type cytokine) induces B cells to produce large amounts of IgE to be secreted into serum and gut lumen, 
or surface-bound onto mast cells. IL-4 also upregulates the expression of low affinity IgE receptor, CD23 (FcεRII), on 
intestinal epithelial cells. Following exposure to dietary allergens, enhanced transepithelial antigen transport is 
mediated by IgE/CD23 prior to mast cell activation during phase I. Transcytosed allergens reach the subepithelial 
lamina propria and cause IgE cross-linking on mast cells, resulting in cell degranulation and anaphylactic responses. 
The release of mast cell mediators, such as histamine, prostaglandin and proteases, are known to induce epithelial 
ion secretion and increased paracellular epithelial permeability in phase II.
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regions between enterocytes in allergic rats.76,78 The 
electrical conductance (measurement of ionic per-
meability through the paracellular pathway) in in-
testinal tissues of allergic rats was comparable to 
those of non-sensitized control animals during phase I. 
This suggests that gut paracellular permeability was 
not modified in response to sensitization per se. 
Moreover, a gradual time-dependent increase in tis-
sue conductance corresponds to the phenomenon 
of enhanced paracellular antigen transport in al-
lergic rats during phase II. The abnormal paracel-
lular epithelial permeability in phase II was absent 
in allergic mast cell-deficient Ws/Ws rats, suggest-
ing a crucial role of mast cell activation in the in-
duction of tight junction opening and increase of 
paracellular influx that was not antigen-specific.
Allergic animal models have shown that en-
hanced transepithelial antigen transport prior to 
mast cell activation is specific for the allergen to 
which the rodents are sensitized, suggesting an im-
munoglobulin recognition mechanism at the level of 
the epithelium.74,75 A low affinity IgE receptor, 
CD23/FcεRII, was previously known for its role in 
regulating IgE synthesis in B cells and promoting B 
cell proliferation.79−81 The expression of CD23 was 
also found in small intestinal epithelial cells in 
normal and food allergic humans and rodents, as 
well as  in bronchial epithelial cells in asthmatic 
patients.75,77,82 Studies in sensitized rat intestines 
have demonstrated the translocations of CD23 from 
cell surface to the membrane of allergen-contain-
ing endosomes, confirming the internal-ization of 
CD23 protein upon luminal antigen challenge.75 Fur-
ther studies using genetically mutant mouse mod-
els provided evidence for the role of IgE/CD23 in 
mediating enhanced transepithelial antigen trans-
port in allergy.77,78 The phenomenon of augmented 
antigen uptake in allergic enterocytes was completely 
absent in sensitized CD23−/− mice and IL-4−/− mice. 
Moreover, the increased transepithelial antigen up-
take in allergic wild type mice was inhibited luminally 
with neutralizing anti-CD23 antibodies.77,78 Passive 
sensitization of naive mice by injecting immune 
serum from allergic mice restored the allergic re-
sponse, but not if IgE was first depleted from serum, 
confirming the crucial role of IgE in antigen uptake. 
In addition, IL-4 increased the expression of CD23 
transcript and protein levels in murine intestinal epi-
thelial cell cultures, as well as allergic mouse ente-
rocytes.77 Overall, enhanced transepithelial antigen 
transport is mediated by IgE/CD23 and regulated 
by IL-4 (Figure 1).
Recent studies indicated that various isoforms of 
CD23 mediated bidirectional transport of IgE across 
the epithelium in allergic murine and human intes-
tines. DNA sequencing revealed the presence of 
classical and alternative CD23b transcripts lacking 
exon 5 (bΔ 5) or 6 (bΔ 6) in mouse enterocytes, all of 
which were translated into functional IgE receptors 
with distinct endocytic properties.78,83 Mouse intes-
tinal epithelial CD23bΔ 5 transcripts mediated apical 
to basolateral transport of free IgE, whereas classi-
cal CD23b transcripts displayed higher efficiency in 
the transcytosis of IgE/allergen complexes.78,83 
Studies using primary human intestinal epithelial 
cells and transformed cell lines have also shown that 
CD23 transports IgE in both the mucosal-to-serosal 
and serosal-to-mucosal directions.84 Both CD23 iso-
forms a and b transfected into human intestinal epi-
thelial cells transcytosed bidirectionally by IgE. 
However, CD23a transport IgE/antigen complex was 
faster than CD23b in the apical-to-basolateral direc-
tion.85 Despite the controversy over which isoform is 
expressed in human enterocytes,84,85 IgE/CD23 is re-
sponsible for enhanced transepithelial antigen up-
take that results in mast cell activation. It is 
noteworthy that food allergens transported via the 
intestinal epithelial IgE/CD23 are protected from 
lysosomal degradation, and therefore, intact anti-
genic forms of the proteins are preserved.86 Taken 
together, these findings suggest that epithelial CD23 
is involved in the bidirectional transport of IgE that 
accounts for the high luminal concentration of IgE in 
allergic situations and the enhanced uptake of IgE-
bound antigen complexes leading to anaphylactic 
responses.
6. Novel Therapeutic Interventions
Currently dietary exclusion is still the most effective 
measure for the prevention of allergic sensitization 
and anaphylactic responses in high-risk children 
and adults. Novel immunotherapy by delivering al-
lergen via subcutaneous or sublingual routes have 
shown some degree of symptom alleviation in ex-
perimental models and human studies, yet large 
scale blinded, placebo-controlled trials are needed 
to confirm the effects for long-term desensitiza-
tion.87 The use of anti-IgE antibody increased the 
threshold of sensitivity to allergens in a double-
blind, randomized, dose-ranging trials for peanut 
allergic patients.88 Moreover, targeting CD23 with 
monoclonal antibody has been shown to decrease 
total serum IgE levels in approximately 75% of pa-
tients in phase I clinical trial of allergic asthma and 
was proposed as candidate therapy for treating al-
lergic diseases for subgroups of patients.89 Additional 
information is needed to develop safe and effective 
treatments for food allergy. The understanding of 
the molecular mechanism underlying epithelial 
barrier defects and induction of allergy may 




1. Ross MP, Ferguson M, Street D, Klontz K, Schroeder T, 
Luccioli S. Analysis of food-allergic and anaphylactic events 
in the National Electronic Injury Surveillance System. 
J Allergy Clin Immunol 2008;121:166−71.
2. De S, I, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 
5 year retrospective review. Allergy 2008;63:1071−6.
3. Herz U. Immunological basis and management of food 
allergy. J Pediatr Gastroenterol Nutr 2008;47(Suppl 2):54−7.
4. Husby S. Food allergy as seen by a paediatric gastroenter-
ologist. J Pediatr Gastroenterol Nutr 2008;47(Suppl 2):49−52.
5. Wills-Karp M, Santeliz J, Karp CL. The germless theory of 
allergic disease: revisiting the hygiene hypothesis. Nature 
Rev Immunol 2001;1:69−75.
6. Strachan DP. Hay fever, hygiene, and household size. BMJ 
1989;299:1259−60.
7. Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too 
clean, or not too clean: the hygiene hypothesis and home 
hygiene. Clin Exp Allergy 2006;36:402−25.
8. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005;
206:232−59.
9. Asai K, Hachimura S, Kimura M, et al. T cell hyporespon-
siveness induced by oral administration of ovalbumin is 
associated with impaired NFAT nuclear translocation and 
p27kip1 degradation. J Immunol 2002;169:4723−31.
10. Keita AV, Gullberg E, Ericson AC, et al. Characterization of 
antigen and bacterial transport in the follicle-associated 
epithelium of human ileum. Lab Invest 2006;86:504−16.
11. Chabot S, Wagner JS, Farrant S, Neutra MR. TLRs regulate 
the gatekeeping functions of the intestinal follicle-associ-
ated epithelium. J Immunol 2006;176:4275−83.
12. Fujihashi K, Dohi T, Rennert PD, et al. Peyer’s patches are 
required for oral tolerance to proteins. Proc Natl Acad Sci 
USA 2001;98:3310−5.
13. Spahn TW, Fontana A, Faria AM, et al. Induction of oral tol-
erance to cellular immune responses in the absence of 
Peyer’s patches. Eur J Immunol 2001;31:1278−87.
14. Spahn TW, Weiner HL, Rennert PD, et al. Mesenteric lymph 
nodes are critical for the induction of high-dose oral toler-
ance in the absence of Peyer’s patches. Eur J Immunol 
2002;32:1109−13.
15. Spahn TW, Kucharzik T. Modulating the intestinal immune 
system: the role of lymphotoxin and GALT organs. Gut 2004;
53:456−65.
16. Tsuji NM, Mizumachi K, Kurisaki J. Antigen-specific, 
CD4 + CD25 + regulatory T cell clones induced in Peyer’s 
patches. Int Immunol 2003;15:525−34.
17. Ishikawa H, Tanaka K, Maeda Y, et al. Effect of intestinal 
microbiota on the induction of regulatory CD25 + CD4 + T 
cells. Clin Exp Immunol 2008;153:127−35.
18. Frossard CP, Tropia L, Hauser C, Eigenmann PA. Lymphocytes 
in Peyer patches regulate clinical tolerance in a murine model 
of food allergy. J Allergy Clin Immunol 2004;113:958−64.
19. Tsuji NM, Mizumachi K, Kurisaki J. Interleukin-10-secreting 
Peyer’s patch cells are responsible for active suppression in 
low-dose oral tolerance. Immunology 2001;103:458−64.
20. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor 
T cells generated by oral tolerization to myelin basic pro-
tein suppress both in vitro and in vivo immune responses 
by the release of transforming growth factor beta after 
antigen-specific triggering. Proc Natl Acad Sci USA 1992;
89:421−5.
21. Chung Y, Lee SH, Kim DH, Kang CY. Complementary role of 
CD4 + CD25 + regulatory T cells and TGF-beta in oral toler-
ance. J Leukoc Biol 2005;77:906−13.
22. Ando T, Hatsushika K, Wako M, et al. Orally administered 
TGF-beta is biologically active in the intestinal mucosa and 
enhances oral tolerance. J Allergy Clin Immunol 2007;120:
916−23.
23. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(+)
CD4(+) regulatory T cells by oral antigen administration. 
J Immunol 2001;167:4245−53.
24. Sun JB, Raghavan S, Sjoling A, Lundin S, Holmgren J. Oral 
tolerance induction with antigen conjugated to cholera 
toxin B subunit generates both Foxp3 + CD25 + and Foxp3-. 
J Immunol 2006;177:7634−44.
25. Coombes JL, Siddiqui KR, Rancibia-Carcamo CV, et al. A 
functionally specialized population of mucosal CD103 + DCs 
induces Foxp3 + regulatory T cells via a TGF-beta and retinoic 
acid-dependent mechanism. J Exp Med 2007;204:1757−64.
26. Roth-Walter F, Berin MC, Arnaboldi P, et al. Pasteurization 
of milk proteins promotes allergic sensitization by enhancing 
uptake through Peyer’s patches. Allergy 2008;63:882−90.
27. Man AL, Bertelli E, Regoli M, Chambers SJ, Nicoletti C. 
Antigen-specific T cell-mediated apoptosis of dendritic cells 
is impaired in a mouse model of food allergy. J Allergy Clin 
Immunol 2004;113:965−72.
28. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. 
EMBO Rep 2006;7:688−93.
29. Cani PD, Delzenne NM. Gut microflora as a target for energy 
and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 
2007;10:729−34.
30. Kelly D, King T, Aminov R. Importance of microbial coloni-
zation of the gut in early life to the development of immu-
nity. Mutat Res 2007;622:58−69.
31. Kelly D, Conway S. Bacterial modulation of mucosal innate 
immunity. Mol Immunol 2005;42:895−901.
32. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase 
in the population of duodenal immunoglobulin A plasmo-
cytes in axenic mice associated with different living or dead 
bacterial strains of intestinal origin. Infect Immun 1978;
21:532−9.
33. Borsutzky S, Cazac BB, Roes J, Guzmán CA. TGF-beta recep-
tor signaling is critical for mucosal IgA responses. J Immunol 
2004;173:3305−7.
34. Mora JR, Iwata M, Eksteen B, et al. Generation of gut-homing 
IgA-secreting B cells by intestinal dendritic cells. Science 
2006;314:1157−60.
35. Johansen FE, Pekna M, Norderhaug IN, et al. Absence of 
epithelial immunoglobulin A transport, with increased mucosal 
leakiness, in polymeric immunoglobulin receptor/secretory 
component-deficient mice. J Exp Med 1999;190:915−22.
36. Van der Waaij LA, Limburg PC, Mesander G, Van der Waaij 
D. In vivo IgA coating of anaerobic bacteria in human feces. 
Gut 1996;38:348−54.
37. Rey J, Garin N, Spertini F, Corthésy B. Targeting of secretory 
IgA to Peyer’s patch dendritic and T cells after transport by 
intestinal M cells. J Immunol 2004;172:3026−33.
38. Kadaoui KA, Corthésy B. Secretory IgA mediates bacterial 
translocation to dendritic cells in mouse Peyer’s patches 
with restriction to mucosal compartment. J Immunol 
2007;179:7751−7.
39. Massacand JC, Kaiser P, Ernst B, et al. Intestinal bacteria 
condition dendritic cells to promote IgA production. PLoS 
One 2008;3:2588.
40. Macpherson AJ, Slack E. The functional interactions of com-
mensal bacteria with intestinal secretory IgA. Curr Opin 
Gastroenterol 2007;23:673−8.
41. Corthésy B. Roundtrip ticket for secretory IgA: role in mucosal 
homeostasis? J Immunol 2007;178:17−32.
42. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The 
requirement of intestinal bacterial flora for the develop-
ment of an IgE production system fully susceptible to oral 
tolerance induction. J Immunol 1997;159:1739−45.
43. Tanaka K, Ishikawa H. Role of intestinal bacterial flora in oral 
tolerance induction. Histol Histopathol 2004;19:907−14.
Epithelial gatekeeper against food allergy 253
44. Oyama N, Sudo N, Sogawa H, Kubo C. Antibiotic use during 
infancy promotes a shift in the T(H)1/T(H)2 balance toward 
T(H)2-dominant immunity in mice. J Allergy Clin Immunol 
2001;107:153−9.
45. Maeda Y, Noda S, Tanaka K, et al. The failure of oral tolerance 
induction is functionally coupled to the absence of T cells 
in Peyer’s patches under germfree conditions. Immunobiology 
2001;204:442−57.
46. Yang PC, Jury J, Soderholm JD, Sherman PM, McKay DM, 
Perdue MH. Chronic psychological stress in rats induces 
intestinal sensitization to luminal antigens. Am J Pathol 
2006;168:104−14.
47. Campbell DE, Hill DJ, Kemp AS. Enhanced IL-4 but normal 
interferon-gamma production in children with isolated IgE 
mediated food hypersensitivity. Pediatr Allergy Immunol 
1998;9:68−72.
48. Hauer AC, Breese EJ, Walker-Smith JA, MacDonald TT. The 
frequency of cells secreting interferon-gamma and inter-
leukin-4, -5, and -10 in the blood and duodenal mucosal of 
children with cow’s milk hypersensitivity. Pediatr Res 1997;
42:629−38.
49. Paul WE. Interleukin 4: a prototypic immunoregulatory 
lymphokine. J Am Soc Hematol 1991;77:1859−70.
50. Belut D, Moneret-Vautrin DA, Nicholas JP, Grilliat JP. IgE 
levels in intestinal juice. Dig Dis Sci 1980;25:323−32.
51. Brown WR, Lee EH. Studies on IgE in human intestinal fluids. 
Int Arch Allergy Appl Immunol 1976;50:87−94.
52. Negrao-Correa D, Adams LS, Bell RG. Intestinal transport 
and catabolism of IgE. J Immunol 1996;157:4037−44.
53. Ramaswamy K, Hakimi J, Bell RG. Evidence for an inter-
leukin 4-inducible immunoglobulin E uptake and transport 
mechanism in the intestine. J Exp Med 1994;180:1793−803.
54. Yu LCH, Perdue MH. Role of mast cells in intestinal mucosal 
function: studies in models of hypersensitivity and stress. 
Immunol Rev 2001;179:61−73.
55. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast 
cells in ion transport abnormalities associated with intesti-
nal anaphylaxis. J Clin Invest 1991;87:687−93.
56. Yu LCH, Perdue MH. Immunologically mediated transport of 
ions and macromolecules. Ann New York Acad Sci 2001;
915:247−59.
57. Crowe SE, Sestini P, Perdue MH. Allergic reactions of rat jeju-
nal mucosa: Ion transport responses to luminal antigen and 
inflammatory mediators. Gastroenterology 1990;99:74−82.
58. Castro GA, Harari Y, Russel D. Mediators of anaphylaxis-
induced ion transport changes in small intestine. Am J 
Physiol 1987;253:540−8.
59. Wasserman SI, Barrett KE, Huott PA, Beuerlein G, Kagnoff 
MF, Dharmsathaphorn K. Immune-related intestinal Cl- 
secretion. I. Effect of histamine on the T84 cell line. Am J 
Physiol 1988;254:53−62.
60. Hardcastle J, Hardcastle PT. The secretory actions of hista-
mine in rat small intestine. J Physiol 1987;388:521−32.
61. Kimberg DV, Field M, Gershon E, Henderson A. Effects of 
prostaglandins and cholera enterotoxin on intestinal 
mucosal cyclic AMP accumulation. Evidence against an 
essential role for prostaglandins in the action of toxin. 
J Clin Invest 1974;53:941−9.
62. Schmitz H, Fromm M, Bode H, Scholz P, Riecken EO, 
Schulzke JD. Tumor necrosis factor-a induces Cl- and K+ 
secretion in human distal colon driven by prostaglandin E2. 
Am J Physiol 1996;271:669−74.
63. Beubler E, Bukhave K, Rask-Madsen J. Significance of cal-
cium for the prostaglandin E2-mediated secretory response 
to 5-hydroxytryptamine in the small intestine of the rat 
in vivo. Gastroenterology 1986;90:1972−7.
64. Heyman M, Ducroc R, Desjeux JF, Morgat JL. Horseradish 
peroxidase transport across adult rabbit jejunum in vitro. 
Am J Physiol 1982;242:558−64.
65. Fujita M, Reinhart F, Neutra M. Convergence of apical and 
basolateral endocytic pathways at apical late endosomes 
in absorptive cells of suckling rat ileum in vivo. J Cell Sci 
1990;97:385−94.
66. Laiping SA, Pelton-Henrion K, Small G, et al. Antigen 
uptake and trafficking in human intestinal epithelial cells. 
Dig Dis Sci 2000;45:1451−61.
67. Clark JA, Coopersmith CM. Intestinal crosstalk: a new para-
digm for understanding the gut as the “motor” of critical 
illness. Shock 2007;28:384−93.
68. Teshima CW, Meddings JB. The measurement and clinical 
significance of intestinal permeability. Curr Gastroenterol 
Rep 2008;10:443−9.
69. Bojarski C, Weiske J, Schoneberg T, et al. The specific fates 
of tight junction proteins in apoptotic epithelial cells. 
J Cell Sci 2004;117:2097−107.
70. Utech M, Ivanov AI, Samarin SN, et al. Mechanism of IFN-
gamma-induced endocytosis of tight junction proteins: 
myosin II-dependent vacuolarization of the apical plasma 
membrane. Mol Biol Cell 2005;16:5040−52.
71. Yu LCH, Flynn AN, Turner JR, Buret AG. SGLT-1-mediated 
glucose uptake protects intestinal epithelial cells against 
LPS-induced apoptosis and barrier defects: a novel cellular 
rescue mechanism? FASEB J 2005;19:1822−35.
72. Shen L, Black ED, Witkowski ED, et al. Myosin light 
chain phosphorylation regulates barrier function by remod-
eling tight junction structure. J Cell Sci 2006;119:
2095−106.
73. Hsiao JK, Huang C-Y, Lu Y-Z, Yang C-Y, Yu LCH. Magnetic 
resonance imaging detects intestinal barrier dysfunction in 
a rat model of acute mesenteric ischemia/reperfusion 
injury. Invest Radiol 2009;44:329−35.
74. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JAJM, 
Perdue MH. Rapid transepithelial antigen transport in rat 
jejunum: impact of sensitization and the hypersensitivity 
reaction. Gastroenterology 1997;113:1−9.
75. Yang PC, Berin MC, Yu LCH, Conrad DH, Perdue MH. 
Enhanced intestinal transepithelial transport in allergic 
rats is mediated by IgE and CD23 (FceRII). J Clin Invest 
2000;106:879−86.
76. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Kitamura Y, Perdue 
MH. The influence of mast cells on pathways of transepi-
thelial antigen transport in rat intestine. J Immunol 1998;
161:2561−6.
77. Yu LCH, Yang PC, Berin MC, et al. Enhanced transepithelial 
antigen transport in intestine of allergic mice is mediated by 
IgE/CD23 and regulated by interleukin-4. Gastroenterology 
2001;121:370−81.
78. Yu LCH, Montagnac G, Yang PC, Conrad DH, Benmerah A, 
Perdue MH. Intestinal epithelial CD23 mediates enhanced 
antigen transport allergy: evidence for novel splice forms. 
Am J Physiol Gastrointest Liver Physiol 2003;285:223−34.
79. Bonnefoy JY, Lecoanet-Henchoz S, Aubry JP, Gauchat JF, 
Graber P. CD23 and B-cell activation. Curr Biol 1995;
7:355−9.
80. Ford JW, Kilmon MA, Haas KM, Shelburne AE, Chan-Li Y, 
Conrad DH. In vivo murine CD23 destabilization enhances 
CD23 shedding and IgE synthesis. Cell Immunol 2006;
243:107−17.
81. Zhang M, Murphy RF, Agrawal DK. Decoding IgE Fc receptors. 
Immunol Res 2007;37:1−16.
82. Kaiserlian D, Lachaux A, Gosjean I, Graber P, Bonnefoy JY. 
Intestinal epithelial cells express the CD23/FceRII mole-
cule: enhances expression in enteropathies. Immunology 
1993;80:90−5.
83. Montagnac G, Yu LC, Bevilacqua C, et al. Differential role 
for CD23 splice forms in apical to basolateral transcytosis 
of IgE/allergen complexes. Traffic 2005;6:230−42.
254 L.C.H. Yu
84. Tu Y, Salim S, Bourgeois J, et al. CD23-mediated IgE transport 
across human intestinal epithelium: inhibition by blocking sites 
of translation or binding. Gastroenterology 2005;129:928−40.
85. Li H, Nowak-Wegrzyn A, Charlop-Powers Z, et al. Transcytosis 
of IgE-antigen complexes by CD23a in human intestinal epi-
thelial cells and its role in food allergy. Gastroenterology 
2006;131:47−58.
86. Bevilacqua C, Montagnac G, Benmerah A, et al. Food aller-
gens are protected from degradation during CD23-mediated 
transepithelial transport. Int Arch Allergy Immunol 2004;
135:108−16.
87. Skripak JM, Sampson HA. Towards a cure for food allergy. 
Curr Opin Immunol 2008;20:690−6.
88. Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-
IgE therapy in patients with peanut allergy. N Engl J Med 
2003;348:986−93.
89. Rosenwasser LJ, Meng J. Anti-CD23. Clin Rev Allergy 
Immunol 2005;29:61−72.
